17D YF Vaccine(Sanofi Pasteur)

Inaugural COP28 Health Day Commitment Advances New Guiding Principles for Financing Climate and Health Solutions, Launched Today DUBAI, UAE, Dec. 2, 2023 /PRNewswire/ -- The Rockefeller Foundation is announcing a USD 100 million commitment to address the health impacts of climate change. Joining 40 multilateral development banks, governments, philanthropies, and civil society organizations, the Foundation also endorsed the Guiding Principles for Financing Climate and Health Solutions, launched today at the World Climate Action Summit, to accelerate investments in and policy development on climate-health solutions that increase country ownership, accessibility, and long-term impact. Continue Reading From left to right Dr. Maria Neira, Irene Atuhairwe, Dr. Christos Christou, Mafalda Duerte, Rajiv Shah, Peter Sands - Leaders meet at the inaugural Health Day at COP28 "Health is the human face of climate change, and Health Day at COP28 is a historic moment for health and climate leaders to commit to advancing the well-being of the 3.3 billion people who are most vulnerable to climate change," said Dr. Rajiv J. Shah, President of The Rockefeller Foundation. "With this commitment, the Foundation and our partners are rising to the occasion to help save lives and improve health outcomes in a warming world." Equitable Financing to Support Country Priorities The inaugural Health Day at COP28 marks a significant step in prioritizing the importance of climate and health on a global scale. The Rockefeller Foundation is committed to amplifying this impact through collaboration with its partners to increase the quantity and effectiveness of financing focused on supporting the efforts of low- and middle-income countries to mitigate, withstand, and respond to the escalating impacts of climate change on health. Though more than 90% of countries including health-focused priorities as part of their National Determined Contributions for climate mitigation and adaptation under the Paris Agreement, recent data suggests only 0.5% of climate financing is allocated toward health projects. Moreover, countries face a bevy of requirements – unique to each funder and imposed on them – when attempting to access funding. The newly released Guiding Principles for Financing Climate and Health Solutions seek to address this financing gap by establishing priorities for funding and policy to support the building of resilient and sustainable health systems. The Principles seek to ensure that countries gain increased access to climate-health financing that is responsive to their people's needs and priorities, especially the most vulnerable. The Republic of Malawi, for example, has endorsed these principles, and will drive climate and health financing accordingly in its Malawi Agenda 2063. The COP28 Presidency in partnership with The Green Climate Fund, the World Health Organization, the Global Fund to Fight AIDS, Tuberculosis and Malaria, and The Rockefeller Foundation developed the Guiding Principles, which were informed by a convening hosted at The Rockefeller Foundation during the United Nations General Assembly. In addition to those partners, more than 50 organizations across climate, finance, health, government, and civil society sectors provided input. Along with the initiating organizations, fellow endorsers include: Adaptation Fund; Africa Centres for Disease Control and Prevention; The Africa Climate Foundation; African Development Bank Group; Amazon Conservation Team Columbia; Amref Health Africa; Asia Venture Philanthropy Network; Belmont Forum; Children's Investment Fund Foundation; Clara Lionel Foundation; Clean Air Fund; Clinton Health Access Initiative; Commonwealth Secretariat; COP28 Presidency; European Investment Bank; Foundation S - The Sanofi Collective; Gavi, the Vaccine Alliance; Global Climate and Health Alliance; Global Environment Facility; The Global Fund to Fight AIDS, Tuberculosis and Malaria; Government of the United Kingdom, Foreign, Commonwealth & Development Office; Green Climate Fund; Health Care Without Harm; Hivos; The Hong Kong Jockey Club's Institute of Philanthropy; IMPACT Europe; International Federation of Red Cross and Red Crescent Societies; Kingdom of Norway, Ministry of Foreign Affairs; OECD Development Centre, Network of Foundations; Pandemic Action Network; PATH; Reaching the Last Mile; Republic of Malawi, Ministry of Health; Robert Wood Johnson Foundation; The Rockefeller Foundation; Save the Children; Seed Global Health; UNICEF; Wellcome Trust; World Bank Group; and World Health Organization. Improving Health for All in a Warming World From its earliest days more than a century ago, The Rockefeller Foundation has sought to improve health outcomes for populations in need. Investments established the first schools of public health and the global campaign against hookworm; and seeded the development of the yellow fever vaccine. The Foundation has also supported translational research for tools ranging from penicillin to polio, helped create the field of molecular biology, spurred AIDS vaccine development, supported Covid-19 responses and pathogen surveillance, and catalyzed and accelerated action on Universal Health Coverage globally. The funding is part of The Rockefeller Foundation's recently announced 5-year Climate Strategy, announced in September, to mobilize USD 1 billion over the next five years to advance the global climate transition and help ensure everyone can participate in it. The USD 100 million climate-health investment will reimagine The Rockefeller Foundation's 110-year legacy in global health for the climate era, seeking to test and scale promising solutions through innovation, equitable financing, policy, and partnerships: Community-driven Innovation: The Foundation is deepening its commitment to health equity by ensuring that the voices and needs of the most vulnerable – women, children, indigenous people, displaced people – are reflected in global climate and health priorities and solutions. Sustainable Financing: The Foundation is working with global donors, development banks, country leaders, and diverse stakeholders to ensure that frontline communities get the financial assistance they need to adapt to climate change in line with the Guiding Principles. We're committed to shaping the market for climate-health investment to support transparent and equitable financing for climate change mitigation and adaptation efforts in low- and middle-income countries. Policy and Partnerships: As a convener and innovator, the Foundation helps merge the priorities of the private sector, government, and the non-profit sector to strengthen our collective response to climate change . Learnings and data from our investments will contribute to the evidence base about what solutions works to inform and drive action. "When it comes to building a livable future, we all have parts to play," said Naveen Rao, Senior Vice President of Health, The Rockefeller Foundation. "Across our commitments, we're developing and strengthening networks focused on reversing the climate crisis and safeguarding health for generations. We're grateful to Reaching the Last Mile, The Hong Kong Jockey Club's Institute of Philanthropy, and other emerging partners for taking up this cause and joining the collective effort." Statements of Support "Climate change is increasing health risks in every region of the world, including millions more people at risk of heat-related illness, food insecurity, infectious diseases, and poverty. A significant mobilization of financing is needed to combat these impacts, which to date have been under-recognized and under-funded. The COP28 Guiding Principles for Financing Climate and Health Solutions is the critical first step to address this, bringing new funders to the table in recognition of the urgent need. We are grateful for our partners stepping up to deliver finance where it is needed most." – Adnan Amin, CEO of COP28 "The impact of climate change on health is not in the distant future, it's here and now. Yet countries lack sufficient resources to adapt health systems for the challenges posed by this crisis. I commend The Rockefeller Foundation for addressing the harm happening today, for unlocking financing for stronger, more resilient health systems, and for making clear that supporting health is an investment, not a cost." – Dr Tedros Adhanom Ghebreyesus, Director-General, World Health Organization "The Institute of Philanthropy (IoP), established and supported by The Hong Kong Jockey Club and its Charities Trust, is committed to work at the intersection of climate and health. IoP shares The Rockefeller Foundation's vision for a climate future that mitigates and adapts to the impact of climate on health for the benefit of everyone, everywhere. Together with fellow funders in the East as well as globally, IoP will leverage its convening capabilities and financial resources to protect future generations from climate change through enhancing resilience and enabling adaptation." – Mr. Winfried Engelbrecht-Bresges GBS JP, Chief Executive Officer of the Hong Kong Jockey Club "I applaud The Rockefeller Foundation's commitment to addressing the Health impacts of climate change. This significant investment, along with the Guiding Principles for Financing Climate and Health Solutions, is pivotal in supporting Climate-Vulnerable countries as they shape Healthier and more Resilient futures. The Foundation's dedication to tailoring Climate-Health investments to align with the specific needs of countries in sub-Saharan Africa and the broader Global South will foster impactful and sustainable action to protect communities against the effects of climate change." – Hon. Khumbize Kandodo Chiponda, MP - Minister of Health, Malawi. About The Rockefeller Foundation The Rockefeller Foundation is a pioneering philanthropy built on collaborative partnerships at the frontiers of science, technology, and innovation that enable individuals, families, and communities to flourish. We make big bets to promote the well-being of humanity. Today, we are focused on advancing human opportunity and reversing the climate crisis by transforming systems in food, health, energy, and finance. For more information, sign up for our newsletter at rockefellerfoundation.org and follow us on X @RockefellerFdn. SOURCE The Rockefeller Foundation

Yellow fever is essentially a mosquito-borne disease, which is more prevalent in African countries as well as in Central and South American region. Often, these diseases are transmitted across the countries via infected travelers, but it is more frequent in countries wherein the mosquito species are able to flourish in a region’s specific climatic conditions and the animal pool required to maintain their prosperity. In 2017, Brazil has notified more than half a dozen separate cases of yellow fever across the country and its prevalence continues to mount in different parts of the world too. As a result, the demand in the global yellow fever treatment market is expected to expand at a steady rate during the forecast period of 2017 to 2025. Factors such as unhygienic lifestyle, increasing awareness among people pertaining to the availability of the treatment to cure yellow fever, improving healthcare infrastructure in several emerging economies, growing number of international travelers, and increased efforts from health organizations such as the UNICEF and the World Health Organization (WHO) are some of the factors augmenting the demand in the global yellow fever treatment market. UNICEF already procures nearly 34 million yellow fever vaccination doses per year and has long-term agreements with four drug companies to provide the vaccination required for routine programmers, emergency, and preventive campaigns. Still, the supply is significantly insufficient to meet the increasing demand, and hence the demand in the global yellow fever treatment market is expected to swell consistently over the course of next few years. GET BROCHURE OF THE REPORT Global Yellow Fever Treatment Market: Overview Yellow fever is caused by a virus transferred through infected Aedes aegypti mosquitoes. These mosquitoes thrive near human dwellings and breed in clean waters. The occurrence of yellow fever is more prevalent in sub-Saharan Africa and tropical South America. Humans and monkeys represent the target patient population infected with yellow fever virus. Yellow fever infection can be lethal as it damages the liver and other internal organs. As per statistics of the World Health Organization, yellow fever affects more than 200,000 individuals every year, of which 90% are reported in Africa. These cases result in 30,000 deaths every year. Factors such as decreasing immunity among the local population, deforestation, and high-density urbanization increases the risk of yellow fever across the world. The report represents facts and figures pertaining to the global yellow fever treatment market in a chronological order. With a scrutiny of past data and current market trends, analysts present a satisfactory picture regarding the market’s future. The users of the report, therefore, receive accurate projections of the global yellow fever treatment market that can be used to formulate cutting-edge business strategies for the future. Using validated analytical tools such as Porter’s Five Forces analysis and SWOT analysis, the report presents valuable insights about the strengths, weakness, opportunities, and threats of the market until the end of the forecast period in 2025. A detailed analysis of the current competitive landscape is included in the report. The section includes a competitive pro the leading players and an analysis of their strengths, weakness, opportunities, and threats for the 2017-2025 period. GET TABLE OF CONTENT OF THE REPORT Global Yellow Fever Treatment Market: Disease Prevention Measures The prevention of yellow fever is essential and vaccination is advised for children above 9 months of age. These vaccines are usually administered by travel medicine clinics and local or state health departments and needs to be repeated every 10 years for individuals who travel frequently to high risk African and Latin American countries. Individuals with compromised immune system or cancer patient, pregnant women, and children below 9 months of age are recommended not to take yellow fever vaccine. Global Yellow Fever Treatment Market: Drivers and Restraints The increasing importance of travel medicine complemented by increasing involvement of respective governments for timely vaccination are the major factors driving the global yellow fever treatment market. However, factors such as demand-supply gap of vaccines and high costs are restraining the growth of this market. As per data provided by the United Nations International Children’s Emergency Fund (UNICEF), there is a large demand-supply gap for yellow fever vaccines. For instance, the demand exceeded supply by almost 44% for the year 2014-2015 despite procurement of all available vaccines by UNICEF. DiTu, LCTA-949, YF-17D, Flaviviruses infection vaccines represent some of the drugs under clinical trials for yellow fever. Major Companies Mentioned in Report Some of the leading companies operating in the global yellow fever treatment market are Panacea Biotech Limited, Themis Bioscience GmbH, Arbovax Inc., and Janssen Pharmaceutcals Inc. Each of the companies is profiled for their attributes of product portfolio, recent developments, and financial standing. GET DISCOUNT ON THE LATEST REPORT TMR Research has rich experience in developing state-of-the-art reports for a wide array of markets and sectors. The brilliance of the experts at TMR Research and their alacrity to conduct thorough research and create phenomenal reports makes TMR Research better than others. 5-Point Growth Formula The 5-point growth formula developed by TMR Research provides an insight to the stakeholders and CXOs about the current situation in the market. The growth formula makes the report a perfect companion for the stakeholders and CXOs. The 5-point growth formula includes the following points: Current and Future Threats Accurate Trend Analysis Regional Assessment Industrial Analogy COVID-19 Impact Current and Future Threats Along with studying the opportunities necessary for growth, threats are also an important aspect to look upon for the companies and stakeholders in a specific sector. TMR Research studies every negative aspect that will hinder the growth of a specific area of business and includes it in the report. The stakeholders and CXOs will have the benefit of assessing the threat and take the necessary steps to prevent the hindrance caused due to the threats. Accurate Trend Analysis Keeping up with the latest trends is crucial in any business or sector. While stakeholders are aware of the trends that are on the surface, TMR Researchers find trends that are deeply entrenched in the particular market or sector. The reports are constantly updated with the latest trends so that the stakeholders and CXOs can derive benefits from the trends and generate good revenues. Regional Assessment Demography forms an important part of the growth pattern of all the markets. Diving deep into the demographics enables maximum output from specific areas. The TMR Research team assesses every region and picks out the vital points that have a large impact on the growth of a market. Industrial Analogy The analysts at TMR Research conduct an all-round analysis on the competitive landscape of the market. The observations recorded by the analysts are added to the reports so that every stakeholder gets a glimpse of the competitive scenario and frame their business plans according to the situation. COVID-19 Impact The COVID-19 outbreak has changed the growth projections of numerous sectors and businesses. The analysts at TMR Research have conducted a conscientious survey on the markets after the pandemic struck. The analysts have put forth their brilliant and well-researched opinions in the report. The opinions will help the stakeholders to plan their strategy accordingly. The reports offer answers to the top 7 questions that revolve around the growth of the market What are the diverse growth parameters influencing the market? Which regions will contribute largely to the growth of the market What are the recent innovations and technological advancements in the market? What are the emerging trends across the market? How has COVID-19 affected the market? What will be the post-pandemic scenario of the market? What are the major threats that will dent the growth prospects of the market? About TMR Research TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends. Contact: Rohit Bhisey TMR Research, 3739 Balboa St # 1097, San Francisco, CA 94121 United States Tel: +1-415-520-1050 Visit Site: